ClearFlow’s mission is to improve patient outcomes and reduce healthcare costs by developing advanced technologies that support best practices and guidelines to prevent chest tube occlusions. ClearFlow’s PleuraFlow® ACT® system is the only device with FDA 510(k)K clearance indicated for the removal of retained blood and the proactive maintenance of chest tube patency after cardiac surgery.
